← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #765 OF 1,000 MOST-CITED

Personnel - hygienic practices

FDA cited this observation 21 times across 20 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods21
BY FISCAL YEAR
FY20245
FY20234
FY20212
FY20201
FY20193
FY20185
FY20171

How FDA worded it — real examples

Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

Country Life, LLC · Hauppauge, New York · Foods · 2024-07-12

Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

Enrinity Supplements, Inc. · Westland, Michigan · Foods · 2024-04-22

Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

NATURE'S FUSIONS, LLC · Orem, Utah · Foods · 2024-04-05

Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

Western Innovations, Inc. · Denver, Colorado · Foods · 2024-02-21

Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

Desert Rose Manufacturing, Inc · Anthony, New Mexico · Foods · 2023-11-29

Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

Sage Woman Herbs, Ltd. dba Sage Consulting & Apothecary · Colorado Springs, Colorado · Foods · 2023-08-30

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →